JBIO Jade Biosciences, Inc.
Nasdaq · SEC CIK 1798749 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 184 since 2021-07-01, latest 2026-06-26 21:20
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Balta Elizabeth | See Remarks | — | — |
| Frohlich Tom | CEO, Dir | — | — |
| King Andrew James | See Remarks | — | — |
| Dahms Bradford D. | CFO | — | — |
| Fairmount Healthcare Fund II L.P. | Dir, 10% | — | — |
Transactions 208
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-06-08 | 2023-06-06 | JBIO | Dake Benjamin T | SEE REMARKS | M - OptEx | $2.05 | +10.3K | 11.6K | +797% | +$21.0K |
| D | 2023-06-07 | 2023-06-05 | JBIO | NIVEN RALPH | CSO | S - Sale+OE | $16.26 | -2,250 | 1,609 | -58% | -$36.6K |
| DM | 2023-06-07 | 2023-06-05 | JBIO | NIVEN RALPH | CSO | M - OptEx | $2.02 | +2,250 | 2,259 | +25,000% | +$4,555 |
| D | 2023-05-23 | 2023-05-19 | JBIO | Gillies Hunter | Chief MEDICAL Off | M - OptEx | $1.74 | +65 | 3,316 | +2% | +$113.10 |
| D | 2023-05-23 | 2023-05-19 | JBIO | Gillies Hunter | Chief MEDICAL Off | S - Sale+OE | $19.50 | -65 | 3,251 | -2% | -$1,268 |
| D | 2023-05-19 | 2023-05-17 | JBIO | Gillies Hunter | Chief MEDICAL Off | S - Sale+OE | $19.59 | -1,090 | 3,251 | -25% | -$21.4K |
| D | 2023-05-19 | 2023-05-17 | JBIO | Gillies Hunter | Chief MEDICAL Off | M - OptEx | $1.74 | +1,090 | 4,341 | +34% | +$1,897 |
| DM | 2023-05-09 | 2023-05-08 | JBIO | Dake Benjamin T | SEE REMARKS | S - Sale+OE | $21.79 | -10.3K | 1,291 | -89% | -$224.1K |
| DM | 2023-05-09 | 2023-05-08 | JBIO | Dake Benjamin T | SEE REMARKS | M - OptEx | $2.05 | +10.3K | 3,704 | New | +$21.0K |
| DM | 2023-05-09 | 2023-05-05 | JBIO | NIVEN RALPH | CSO | S - Sale+OE | $20.87 | -2,250 | 1,814 | -55% | -$46.9K |
| DM | 2023-05-09 | 2023-05-05 | JBIO | NIVEN RALPH | CSO | M - OptEx | $2.02 | +2,250 | 3,859 | +140% | +$4,555 |
| 2023-05-05 | 2023-05-03 | JBIO | Verwijs Marinus | SVP, CMC | S - Sale | $20.79 | -759 | 0 | -100% | -$15.8K | |
| DM | 2023-05-03 | 2023-05-01+ | JBIO | NOYES TIMOTHY P | CEO, Dir | S - Sale+OE | $20.63 | -15.7K | 693 | -96% | -$323.8K |
| D | 2023-05-03 | 2023-05-01 | JBIO | NOYES TIMOTHY P | CEO, Dir | M - OptEx | $2.14 | +15.0K | 15.7K | +2,165% | +$32.1K |
| D | 2023-04-25 | 2023-04-21 | JBIO | Gillies Hunter | Chief MEDICAL Off | S - Sale+OE | $19.50 | -4,000 | 1,960 | -67% | -$78.0K |
| D | 2023-04-25 | 2023-04-21 | JBIO | Gillies Hunter | Chief MEDICAL Off | M - OptEx | $1.74 | +4,000 | 5,960 | +204% | +$6,960 |
| DM | 2023-04-07 | 2023-04-06 | JBIO | Dake Benjamin T | SEE REMARKS | M - OptEx | $2.05 | +10.3K | 10.3K | New | +$21.0K |
| D | 2023-04-07 | 2023-04-06 | JBIO | Dake Benjamin T | SEE REMARKS | S - Sale+OE | $18.17 | -10.3K | 0 | -100% | -$186.8K |
| DM | 2023-04-07 | 2023-04-05 | JBIO | NIVEN RALPH | CSO | S - Sale+OE | $18.20 | -2,250 | 2,144 | -51% | -$40.9K |
| DM | 2023-04-07 | 2023-04-05 | JBIO | NIVEN RALPH | CSO | M - OptEx | $2.02 | +2,250 | 3,859 | +140% | +$4,555 |
| DM | 2023-04-05 | 2023-04-03 | JBIO | NOYES TIMOTHY P | CEO, Dir | S - Sale+OE | $19.40 | -15.0K | 5,828 | -72% | -$291.0K |
| D | 2023-04-05 | 2023-04-03 | JBIO | NOYES TIMOTHY P | CEO, Dir | M - OptEx | $2.14 | +15.0K | 15.0K | New | +$32.1K |
| DM | 2023-03-08 | 2023-03-06 | JBIO | Dake Benjamin T | SEE REMARKS | M - OptEx | $2.05 | +10.3K | 10.3K | New | +$21.0K |
| DM | 2023-03-08 | 2023-03-06 | JBIO | Dake Benjamin T | SEE REMARKS | S - Sale+OE | $23.73 | -10.3K | 0 | -100% | -$244.0K |
| DM | 2023-03-08 | 2023-03-06 | JBIO | NIVEN RALPH | CSO | S - Sale+OE | $23.75 | -2,250 | 1,654 | -58% | -$53.4K |
| DM | 2023-03-08 | 2023-03-06 | JBIO | NIVEN RALPH | CSO | M - OptEx | $2.02 | +2,250 | 3,859 | +140% | +$4,555 |
| D | 2023-03-03 | 2023-03-01 | JBIO | NOYES TIMOTHY P | CEO, Dir | M - OptEx | $2.14 | +15.0K | 15.0K | New | +$32.1K |
| DM | 2023-03-03 | 2023-03-01 | JBIO | NOYES TIMOTHY P | CEO, Dir | S - Sale+OE | $23.81 | -15.0K | 0 | -100% | -$357.2K |
| DM | 2023-02-08 | 2023-02-06 | JBIO | NIVEN RALPH | CSO | M - OptEx | $2.02 | +2,250 | 3,859 | +140% | +$4,555 |
| D | 2023-02-08 | 2023-02-06 | JBIO | NIVEN RALPH | CSO | S - Sale+OE | $24.27 | -2,250 | 1,609 | -58% | -$54.6K |
| DM | 2023-02-08 | 2023-02-06 | JBIO | Dake Benjamin T | SEE REMARKS | M - OptEx | $2.05 | +10.3K | 10.3K | New | +$21.0K |
| DM | 2023-02-08 | 2023-02-06 | JBIO | Dake Benjamin T | SEE REMARKS | S - Sale+OE | $24.59 | -10.3K | 1,426 | -88% | -$252.9K |
| DM | 2023-02-03 | 2023-02-01 | JBIO | NOYES TIMOTHY P | CEO, Dir | S - Sale+OE | $22.68 | -15.0K | 0 | -100% | -$340.2K |
| D | 2023-02-03 | 2023-02-01 | JBIO | NOYES TIMOTHY P | CEO, Dir | M - OptEx | $2.14 | +15.0K | 15.0K | New | +$32.1K |
| DM | 2023-01-09 | 2023-01-05 | JBIO | NIVEN RALPH | CSO | M - OptEx | $2.02 | +2,250 | 2,259 | +25,000% | +$4,555 |
| D | 2023-01-09 | 2023-01-05 | JBIO | NIVEN RALPH | CSO | S - Sale+OE | $26.40 | -2,250 | 1,609 | -58% | -$59.4K |
| DM | 2023-01-09 | 2023-01-06 | JBIO | Dake Benjamin T | SEE REMARKS | M - OptEx | $2.05 | +10.3K | 10.3K | New | +$21.0K |
| DM | 2023-01-09 | 2023-01-06 | JBIO | Dake Benjamin T | SEE REMARKS | S - Sale+OE | $25.98 | -10.3K | 0 | -100% | -$267.2K |
| DM | 2023-01-05 | 2023-01-03 | JBIO | NOYES TIMOTHY P | CEO, Dir | S - Sale+OE | $27.07 | -15.0K | 0 | -100% | -$406.1K |
| D | 2023-01-05 | 2023-01-03 | JBIO | NOYES TIMOTHY P | CEO, Dir | M - OptEx | $2.14 | +15.0K | 15.0K | New | +$32.1K |
| DM | 2022-12-14 | 2022-12-12 | JBIO | Dake Benjamin T | SEE REMARKS | S - Sale+OE | $29.43 | -2,059 | 907 | -69% | -$60.6K |
| D | 2022-12-14 | 2022-12-12 | JBIO | Dake Benjamin T | SEE REMARKS | M - OptEx | $2.14 | +2,059 | 2,059 | New | +$4,406 |
| DM | 2022-12-13 | 2022-12-09+ | JBIO | Eldridge George A | SEE REMARKS | M - OptEx | $2.14 | +14.0K | 5,929 | New | +$29.9K |
| DM | 2022-12-13 | 2022-12-09+ | JBIO | Eldridge George A | SEE REMARKS | S - Sale+OE | $28.43 | -14.0K | 1,960 | -88% | -$397.2K |
| DM | 2022-12-12 | 2022-12-08+ | JBIO | Dake Benjamin T | SEE REMARKS | S - Sale+OE | $22.73 | -10.4K | 6,377 | -62% | -$236.3K |
| DM | 2022-12-12 | 2022-12-08+ | JBIO | Dake Benjamin T | SEE REMARKS | M - OptEx | $2.14 | +10.4K | 10.0K | New | +$22.2K |
| DM | 2022-12-09 | 2022-12-07+ | JBIO | Eldridge George A | SEE REMARKS | S - Sale+OE | $21.85 | -23.6K | 1,960 | -92% | -$516.8K |
| DM | 2022-12-09 | 2022-12-07+ | JBIO | Eldridge George A | SEE REMARKS | M - OptEx | $2.14 | +23.6K | 13.6K | New | +$50.6K |
| DM | 2022-12-08 | 2022-12-06 | JBIO | Dake Benjamin T | SEE REMARKS | M - OptEx | $2.12 | +40.0K | 40.0K | New | +$84.6K |
| DM | 2022-12-08 | 2022-12-06 | JBIO | Dake Benjamin T | SEE REMARKS | S - Sale+OE | $17.67 | -40.0K | 0 | -100% | -$706.8K |
| DM | 2022-12-07 | 2022-12-05 | JBIO | NIVEN RALPH | CSO | M - OptEx | $2.02 | +2,250 | 3,859 | +140% | +$4,555 |
| D | 2022-12-07 | 2022-12-05 | JBIO | NIVEN RALPH | CSO | S - Sale+OE | $17.38 | -2,250 | 1,609 | -58% | -$39.1K |
| D | 2022-12-02 | 2022-11-30 | JBIO | Eldridge George A | SEE REMARKS | M - OptEx | $2.14 | +85 | 2,045 | +4% | +$181.90 |
| D | 2022-12-02 | 2022-11-30 | JBIO | Eldridge George A | SEE REMARKS | S - Sale+OE | $19.06 | -85 | 1,960 | -4% | -$1,620 |
| D | 2022-12-02 | 2022-12-01 | JBIO | NOYES TIMOTHY P | CEO, Dir | S - Sale+OE | $18.00 | -15.0K | 0 | -100% | -$270.0K |
| D | 2022-12-02 | 2022-12-01 | JBIO | NOYES TIMOTHY P | CEO, Dir | M - OptEx | $2.14 | +15.0K | 15.0K | New | +$32.1K |
| D | 2022-11-28 | 2022-11-23 | JBIO | Eldridge George A | SEE REMARKS | S - Sale+OE | $19.07 | -1,261 | 1,960 | -39% | -$24.0K |
| D | 2022-11-28 | 2022-11-23 | JBIO | Eldridge George A | SEE REMARKS | M - OptEx | $2.14 | +1,261 | 3,221 | +64% | +$2,699 |
| DM | 2022-11-22 | 2022-11-18+ | JBIO | Eldridge George A | SEE REMARKS | S - Sale+OE | $19.43 | -1,037 | 1,960 | -35% | -$20.1K |
| DM | 2022-11-22 | 2022-11-18+ | JBIO | Eldridge George A | SEE REMARKS | M - OptEx | $2.14 | +1,037 | 2,821 | +58% | +$2,219 |
| DM | 2022-11-14 | 2022-11-09+ | JBIO | Dake Benjamin T | SEE REMARKS | S - Sale+OE | $18.87 | -22.0K | 0 | -100% | -$415.2K |
| DM | 2022-11-14 | 2022-11-09+ | JBIO | Dake Benjamin T | SEE REMARKS | M - OptEx | $2.14 | +22.0K | 14.0K | New | +$47.1K |
| DM | 2022-11-09 | 2022-11-07+ | JBIO | Dake Benjamin T | SEE REMARKS | S - Sale+OE | $18.25 | -26.0K | 6,505 | -80% | -$474.4K |
| DM | 2022-11-09 | 2022-11-07+ | JBIO | Dake Benjamin T | SEE REMARKS | M - OptEx | $2.10 | +26.0K | 2,413 | New | +$54.7K |
| DM | 2022-11-09 | 2022-11-07 | JBIO | NIVEN RALPH | CSO | S - Sale+OE | $19.19 | -2,250 | 1,609 | -58% | -$43.2K |
| DM | 2022-11-09 | 2022-11-07 | JBIO | NIVEN RALPH | CSO | M - OptEx | $2.02 | +2,250 | 2,259 | +25,000% | +$4,555 |
| 2022-11-03 | 2022-11-02 | JBIO | Verwijs Marinus | SVP, CMC | S - Sale | $18.89 | -1,130 | 0 | -100% | -$21.3K | |
| 2022-11-03 | 2022-11-01 | JBIO | NOYES TIMOTHY P | CEO, Dir | S - Sale | $19.50 | -1,038 | 0 | -100% | -$20.2K | |
| D | 2022-10-20 | 2022-10-18 | JBIO | Dake Benjamin T | SEE REMARKS | S - Sale+OE | $21.08 | -5,705 | 0 | -100% | -$120.3K |
| D | 2022-10-20 | 2022-10-18 | JBIO | Dake Benjamin T | SEE REMARKS | M - OptEx | $2.14 | +5,705 | 5,705 | New | +$12.2K |
| DM | 2022-10-18 | 2022-10-14+ | JBIO | Dake Benjamin T | SEE REMARKS | M - OptEx | $2.14 | +4,295 | 4,185 | New | +$9,191 |
| DM | 2022-10-18 | 2022-10-14+ | JBIO | Dake Benjamin T | SEE REMARKS | S - Sale+OE | $20.16 | -4,295 | 0 | -100% | -$86.6K |
| DM | 2022-10-12 | 2022-10-10 | JBIO | Dake Benjamin T | SEE REMARKS | S - Sale+OE | $16.89 | -4,954 | 0 | -100% | -$83.7K |
| D | 2022-10-12 | 2022-10-10 | JBIO | Dake Benjamin T | SEE REMARKS | M - OptEx | $2.14 | +4,954 | 4,954 | New | +$10.6K |
| DM | 2022-10-11 | 2022-10-06+ | JBIO | Dake Benjamin T | SEE REMARKS | S - Sale+OE | $15.91 | -23.6K | 0 | -100% | -$374.7K |
| DM | 2022-10-11 | 2022-10-06+ | JBIO | Dake Benjamin T | SEE REMARKS | M - OptEx | $2.10 | +23.6K | 13.0K | New | +$49.5K |
| DM | 2022-10-07 | 2022-10-05 | JBIO | NIVEN RALPH | CSO | S - Sale+OE | $15.75 | -2,250 | 1,800 | -56% | -$35.4K |
| DM | 2022-10-07 | 2022-10-05 | JBIO | NIVEN RALPH | CSO | M - OptEx | $2.02 | +2,250 | 2,259 | +25,000% | +$4,555 |
| D | 2022-09-14 | 2022-09-12 | JBIO | Dake Benjamin T | SEE REMARKS | M - OptEx | $2.14 | +7,520 | 7,520 | New | +$16.1K |
| DM | 2022-09-14 | 2022-09-12 | JBIO | Dake Benjamin T | SEE REMARKS | S - Sale+OE | $17.32 | -7,520 | 0 | -100% | -$130.3K |
| DM | 2022-09-12 | 2022-09-08+ | JBIO | Dake Benjamin T | See Remarks | S - Sale+OE | $17.80 | -7,840 | 0 | -100% | -$139.6K |
| DM | 2022-09-12 | 2022-09-08+ | JBIO | Dake Benjamin T | See Remarks | M - OptEx | $1.97 | +7,840 | 3,120 | New | +$15.4K |
| DM | 2022-09-08 | 2022-09-06+ | JBIO | Dake Benjamin T | See Remarks | S - Sale+OE | $18.50 | -12.8K | 606 | -95% | -$237.3K |
| DM | 2022-09-08 | 2022-09-06+ | JBIO | Dake Benjamin T | See Remarks | M - OptEx | $1.74 | +17.4K | 9,166 | New | +$30.3K |
| D | 2022-09-07 | 2022-09-06 | JBIO | NIVEN RALPH | CSO | S - Sale+OE | $19.00 | -2,250 | 1,609 | -58% | -$42.8K |
| DM | 2022-09-07 | 2022-09-06 | JBIO | NIVEN RALPH | CSO | M - OptEx | $2.02 | +2,250 | 3,859 | +140% | +$4,555 |
| D | 2022-08-19 | 2022-08-18 | JBIO | NIVEN RALPH | CSO | S - Sale+OE | $21.18 | -2,250 | 1,609 | -58% | -$47.7K |
| DM | 2022-08-19 | 2022-08-18 | JBIO | NIVEN RALPH | CSO | M - OptEx | $2.02 | +2,250 | 2,259 | +25,000% | +$4,555 |
| DM | 2022-08-18 | 2022-08-16 | JBIO | Dake Benjamin T | See Remarks | S - Sale+OE | $23.00 | -21.0K | 0 | -100% | -$483.0K |
| D | 2022-08-18 | 2022-08-16 | JBIO | Dake Benjamin T | See Remarks | M - OptEx | $1.74 | +21.0K | 21.0K | New | +$36.5K |
| DM | 2022-08-12 | 2022-08-10+ | JBIO | Dake Benjamin T | See Remarks | M - OptEx | $1.74 | +14.1K | 1,347 | New | +$24.5K |
| DM | 2022-08-12 | 2022-08-10+ | JBIO | Dake Benjamin T | See Remarks | S - Sale+OE | $24.07 | -14.1K | 780 | -95% | -$338.6K |
| DM | 2022-08-10 | 2022-08-08+ | JBIO | Dake Benjamin T | See Remarks | S - Sale+OE | $24.31 | -15.6K | 2,954 | -84% | -$380.3K |
| DM | 2022-08-10 | 2022-08-08+ | JBIO | Dake Benjamin T | See Remarks | M - OptEx | $1.74 | +15.6K | 6,943 | New | +$27.2K |
| 2022-07-19 | 2022-07-15 | JBIO | Atlas Venture Fund XII, L.P. | 10% | J - Other | $0.00 | -310.4K | 2.33M | -12% | $0 | |
| 2022-04-04 | 2022-04-01 | JBIO | Atlas Venture Fund XII, L.P. | 10% | J - Other | $0.00 | -465.6K | 2.64M | -15% | $0 | |
| DI | 2021-07-07 | 2021-07-02 | JBIO | Cormorant Global Healthcare Master Fund, LP | Former 10% Owner | C - Cnv Deriv | — | +1.53M | 1.53M | New | — |
| DI | 2021-07-07 | 2021-07-02 | JBIO | Cormorant Global Healthcare Master Fund, LP | Former 10% Owner | P - Purchase | $14.00 | +500.0K | 2.03M | +33% | +$7.00M |
| DMI | 2021-07-06 | 2021-07-02 | JBIO | Shah Rajeev M. | Dir, 10% | C - Cnv Deriv | — | +5.24M | 4.18M | New | — |
| DI | 2021-07-06 | 2021-07-02 | JBIO | Shah Rajeev M. | Dir, 10% | P - Purchase | $14.00 | +2.79M | 6.97M | +67% | +$39.00M |
Purchase Sale Sale after option exercise All abbreviations